Science2 distinct publishers3 min readUpdated
Basel researchers mapped 162 mouse brains to find wake-activated cells in the median raphe and preoptic area. Switching them off cut sleep by nearly 70 per cent, with no rebound.
The Scientist · Science desk

Compiled by The ScientistSomething wrong?How this is made
A group at the University of Basel has identified wake-activated neurons in mice that encode accumulated sleep deficit, and has shown that turning them on produces something resembling recovery sleep while turning them off erases the urge to catch up [1][2][3][4]. Homeostatic sleep drive has been a quantity inferred from behaviour and EEG for decades; this makes it a set of addressable cells.
The mapping came first. Mice were kept awake for six hours at the start of the light phase, their rest phase, using induced grooming or exposure to novel objects [5]. Brains were then stained for FOS, a marker of recently activated neurons, cleared, and imaged by light sheet at four points during deprivation and two during a three-hour recovery window [6]. Dark-phase deprivation and ordinary three-hour circadian intervals served as controls for stimulus-specific and time-of-day effects [7]. Across 162 brains and 26 conditions, voxel-wise clustering separated three response profiles: an early-peaking type that tracks the onset of the deprivation stimulus and peaks 1.5 to 3 hours in, a sleep-correlated type, and a wake-correlated type that scales with time awake [8][9]. The anterior medial preoptic area and the median raphe fell into the third category [1].
Then the interventions. Activating the deprivation-responsive cells in those regions increased both sleep duration and sleep intensity, the latter measured as delta-band EEG power around 0.5 to 4 Hz [3][10]. According to New Scientist, mice with both median raphe populations activated slept two to three times as long as controls and spent more time in non-REM slow-wave sleep [11]. Inhibition ran the other way: less sleep, and, critically, no rise in sleep propensity during deprivation at all [4]. The deficit signal was not merely muted; it was not produced.
The responsive cells in the median raphe include serotonergic neurons and a separate GABAergic population whose intrinsic excitability rises during deprivation [12]. They project to subcortical sleep-associated regions and act through the preoptic hypothalamus [13]. Co-activating both types promotes sleep synergistically; co-inhibiting both chronically cuts sleep by nearly 70 per cent [14].
That last figure carries the strangest result. Chronically inhibited mice lost about 6.5 hours of sleep per day, implying a baseline near 9.3 hours and a residual under three [15][16]. The Nature authors report that most animals survived without the compensatory sleep drive or behavioural deficits that severe deprivation normally causes [17], and New Scientist reports no increase in the anxiety-like behaviours mice usually show [15]. But roughly 17 per cent of the mice died, meaning about 83 per cent survived [18][19]. "Most survive" and "one in six does not" are both true statements about the same experiment, and the second one constrains any therapeutic reading of the first.
Two caveats are load-bearing. Whether the equivalent populations exist in humans is unknown, and the researchers say therapy would depend on first working out how the cells talk to other regions [20]. And this is one path among several: Mark Wu at Johns Hopkins, whose group has implicated the thalamic nucleus reuniens in tracking the gap between sleep needed and sleep obtained, places the work in a growing set of wake-activated, sleep-promoting circuits [21], while Luis de Lecea at Stanford notes that the brain has many ways to fall asleep and wake up [22]. Chiara Cirelli at Wisconsin-Madison called the whole-brain FOS mapping a tour de force [23].
What to watch: whether the 70 per cent reduction holds without rebound over longer horizons, what killed the 17 per cent, and whether the GABAergic excitability shift has any measurable human correlate.
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
By comparing whole-brain responses to sleep deprivation, recovery sleep and circadian behaviour in mice, researchers identified the anterior medial preoptic area and the median raphe as candidate regions that encode sleep deficit.
The study used whole-brain activity mapping, targeted neuronal manipulations and electrophysiology to identify wake-activated neurons that regulate sleep drive in mice.
Activating sleep-deprivation-responsive cells in the anterior medial preoptic area and median raphe induces increases in sleep duration and intensity that resemble recovery sleep.
When both sets of median raphe neurons were artificially activated, the mice slept for twice or three times as long as control mice and spent more time in non-REM slow-wave sleep, according to New Scientist.
The deprivation-sensitive cells include serotonergic neurons and a distinct population of GABAergic neurons whose intrinsic excitability increases during sleep deprivation.
Neurons in the median raphe that respond to sleep deprivation project to subcortical sleep-associated regions and act through the preoptic hypothalamus.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Strong primary evidence, single lab, mouse only
The core claims come from a peer-reviewed Nature paper with an unusually large activation-mapping dataset (162 brains, 26 conditions), two independent deprivation stimuli, dark-phase and circadian controls, bidirectional causal manipulation, projection tracing and electrophysiology, and three independent sleep researchers commenting on the record. Evidence is nonetheless from one group in one species, and the mortality figure appears only in secondary coverage.
Preclinical; one public dataset artifact
The only concrete uptake artifacts in the supplied material are the published paper and the companion public whole-brain atlas that other labs can query. There is no human work, no clinical or product deployment, and the sources state that whether the populations even exist in humans is unknown, with therapeutic use framed as conditional on further circuit mapping.
Modestly overstated framing over solid mouse data
Framing runs slightly ahead of the evidence: headline language about knowing which neurons dictate sleep, and the abstract's 'remarkably, most mice survive' without a mortality number, sit against a mouse-only result where about 17% of chronically inhibited animals died and human circuit existence is unknown. The overstatement is bounded because both publishers keep the causal claims accurate and New Scientist carries the lethality figure, the human caveat and a specialist noting the brain has many parallel sleep-wake paths.
Author promotion, partly offset by independent voices
The visible incentive is ordinary academic promotion: the lead group's own members characterise their neurons as crucial to sleep drive, and one commenting researcher relates the work to his own nucleus reuniens findings. Offsetting that, two of three quoted commentators are unaffiliated with the study and one adds an explicit deflationary caveat. No funding sources, competing interests or commercial ties appear in the supplied material, so this reading is based only on affiliation and quotation patterns.
High on mechanism, low on translation
Two sources that agree on mechanism, one of them the peer-reviewed primary report with a public dataset, support high confidence in the mouse findings. Confidence is held below that ceiling because key risk numbers (mortality) rest on a single secondary account, no disclosures are supplied, and nothing in the material speaks to replication elsewhere or human relevance.
science
A phage kinase with no target list: EMBL finds one enzyme that breaks several bacterial defences1 distinct publisher
science
HIPAA Covers Less Than You Think, And "Anonymized" Is Not A Legal Shield1 distinct publisher
product
LLNL closes a 20 percent gap in diamond melting, and stakes a fusion gain claim on it1 distinct publisher
science
Psilocybin's 'oneness' now has a brain-network correlate, and it was found by sorting people on self-report1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 18, 2026
1 article · August 19, 2026